Autolus Therapeutics plc ADR (NASDAQ: AUTL) Rose 2.91% In Six Months, Here’s What We Should Expect Now
During the recent session, Autolus Therapeutics plc ADR (NASDAQ:AUTL)’s traded shares were 0.51 million, with the beta value of the company hitting 2.00. At the